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Abstract  
In this dissertation, we review how plasticity in the modes of cell migration can occur in 
response to changes in the extracellular matrix. Different modes of migration exhibit varying 
characteristics, such as cell adhesion, membrane protrusion, and proteolysis, allowing tumor cells 
to adapt to their current extracellular environment, thus enhancing invasive behavior in response 
to different antitumorigenic therapies. The combination of various cell migration characteristics 
results in a distinct mode of single-cell migration, which, for single-cell migration, falls under 
two general modes, mesenchymal-traction-force motility or amoeboid-propulsion-squeeze 
motility. 
Mesenchymal-to-amoeboid transition is known to occur when tumor cells are in a softer 
matrix with low adhesion and in a high-confinement environment. Under these conditions the 
tumor cells exhibit higher levels of cortical myosin activity. Amoeboid migration is characterized 
by high cortical contractility, mediated by increased myosin activity along the cell cortex. 
Understanding how contractility is increased under changes in adhesion and confinement is 
important to uncover the possible mechanisms a tumor cell uses to optimize motility. Here, I will 
introduce a model that explores how the differential regulation of RhoGTPases (Rac1 and RhoA) 
is modulated with changes in cell-matrix adhesion and cell-matrix confinement to induce 
mesenchymal-to-amoeboid-transition. In the model, tumor cells in soft matrix are exposed to 
fewer ligands to which they can bind their integrins and activate Rac1. Loss of Rac1 activation in 
soft matrix inhibits lamellipodia formation, and the double-negative relationship between Rac1 
and RhoA will shift towards RhoA to promote increase cortical myosin activity for amoeboid 
migration (Figure 1). Myosin activity is further enhanced under confinement through retrograde 
flow and recycling of transmembrane protein like integrin and syndecan, which results in increase 
of RhoA-mediated contractility for amoeboid migration.  
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Introduction  
Plasticity in the modes of migration is important in developmental biology, tumor 
progression, and immune activity (Friedl and Wolf, 2010). This migratory plasticity is described 
as a reversible transition between different modes of migratory phenotypes. There are two 
dominant modes a migrating-single-cell can develop, the amoeboid mode which has a round 
shape and squeezes its plasma membrane to move through the environment, and the other is the 
mesenchymal mode which is elongated and uses adhesion molecules to move. Each mode has its 
own distinct cytoskeletal features and adhesion properties to produce different forms of mobility 
     
Figure 1: Left panel, Cell membrane with focal adhesion in soft matrix. There are fewer ligands in soft matrix for focal 
adhesions to interact, resulting in inactivation of focal adhesions. Rac1 will not translocated to focal adhesions and 
become active. Inactive Rac1 will prevent inhibition of RhoA. RhoA activation will promote actin and myosin 
formation along cortical membranes and enable amoeboid transition. Right panel, Cell membrane in stiff matrix. Focal 
adhesion will bind to abundant and exposed ligands to become activated. Activated focal adhesions will recruit Rac1 
to activate actin polymerizing proteins for lamellipodia. Rac1 also inhibits RhoA to prevent myosin activity. 
Activation of Rac1 favors mesenchymal migration.  
7 
 
within their respective tissue environment (Figure 2). Cells in normal tissues are connected and 
supported by an extracellular matrix scaffold that can influence cell shape and behavior through 
its biochemical and mechanical stimuli (Frantz et al., 2010).  
The extracellular matrix is part of a microenvironment that is highly dynamic, because it 
is constantly being remodeled to achieve tissue structure homeostasis. Under pathological 
conditions, like cancer, matrix components are dysregulated resulting in drastic changes to the 
extracellular environment. (Walker et al., 2018). Cancer cells can use cell plasticity to optimize 
survivability and invasion in the altered matrix. A similar adaption can occur in tumor cells in 
response to chemotherapies (Taddei et al., 2014). When an anti-tumor therapy is targeting a 
component of cell adhesion that is necessary for mesenchymal cell migration, the tumor cell can 
initiate a transition to the alternative amoeboid mode and provide chemoresistance (Taddei et al., 
2014; Talkenberger et al., 2017). This tumor cell plasticity is also useful for immune-surveillance 
escape. When immune cells are targeting tumor mesenchymal components, the tumor cell can 
transition into an amoeboid mode and prevent recognition from immune cells (Lorenzo-Sanz and 
Muñoz, 2019; Terry et al., 2017).  Although tumor cells can exhibit both types of migratory 
modes, those that can transition from mesenchymal to amoeboid are associated with aggressive 
 
Figure 2: Cellular and ECM determinants for respective modes of cell migration. Collective migration 
(pink/orange) will be favored with loose and stiff ECM, high cell-cell adhesion, high cell-matrix adhesion, cellular 
protrusion via Rac and high proteolysis. Mesenchymal mode (dark blue) is favored in dense and stiff matrix, very 
low cell-cell adhesion, high cell-matrix adhesion, high cellular protrusion and proteolysis. Amoeboid (green/light 
blue) is favored under lose and soft ECM, low cell-cell adhesion, low cell-matrix adhesion, high cytoskeleton 
contraction via RhoA/ROCK, low protrusion and no proteolytic activity. Cell shape and behavior is modulated in 
response to ECM changes that cause changes in cellular signaling. Figure from: Friedl, P., and Wolf, K. (2010). 
Plasticity of cell migration: a multiscale tuning model. The Journal of Cell Biology 188, 11-19. Creative 
Commons; https://creativecommons.org/licenses/by-nc-sa/3.0/ 
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metastatic cancers (Pastushenko and Blanpain, 2019). Understanding the causes of the tumor cell 
transitions can potentially serve as a platform to develop new interventions that help prevent 
invasion, chemoresistance, and immune escape in cancer patients. 
The transition between the two modes is correlated with aberrant changes in the 
extracellular matrix (like growth factor and cytokine expression), chemotaxis, durotaxis, spatial 
confinement, hypoxia, cell-matrix interactions, and cell-cell interactions, all of which are 
progressive features of tumorigenesis (Wang et al., 2017). These changes are thought to be 
created through genetic mutations and abnormal signaling between tumor cells and benign cells, 
resulting in a complex environment that enhances transitions between modes of cell migration 
and optimizes malignancy (Hecht et al., 2015).  
Mesenchymal to amoeboid transitions can be influenced by the mechanical properties of 
the extracellular matrix (ECM). The mechanical signal of the matrix can be finely-tuned by 
altering matrix stiffness/rigidity, adhesion, and spatial confinement (Bergert et al., 2012; Friedl 
and Wolf, 2010; Panková et al., 2010; Talkenberger et al., 2017). In general, increasing cell-
matrix adhesion (seen in stiff matrix) and decreasing cell-matrix confinement can support a 
mesenchymal cell phenotype (Friedl and Wolf, 2010). On the other side of the transition 
spectrum, by decreasing cell-matrix adhesion (seen in soft matrix) (Alvarez-Gonzalez et al., 
2015; Ruprecht et al., 2015) and increasing cell-matrix confinement (Liu et al., 2015), it can 
promote an amoeboid cell phenotype. The new model in this paper may explain why we see 
tumor cells undergo these changes under different environmental conditions.  
The mechanical mechanism to promote these phenotypes in their respective conditions is 
still unknown. However, there is a significant difference in cortical contractility when cells are in 
different matrix adhesion and confinement conditions. This may explain why there are transitions 
between cell migration, since amoeboid mode is heavily dependent on cortical contractility 
(Jacobelli et al., 2010; Ruprecht et al., 2015). Additionally, RhoA is a mechanical-sensitive 
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GTPase that is differentially up-regulated in amoeboid migration and causes an increase in 
myosin contractility (Parri and Chiarugi, 2010). Here, we will explore different signaling 
pathways that regulate RhoGTPases (RhoA and Rac1) and then speculate how they could be 
modulated under different cell-matrix adhesion and cell-matrix confinement to favor 
mesenchymal-to-amoeboid transition 
Modes of Migration: Collective and Individual Cell Migration 
 Cell migration is facilitated through either a collective action, by traveling bound to other 
cells, or by being a single-cell that translocates individually to a distal site (Friedl and Alexander, 
2011). Single-cell migration carries two extreme subclasses or modes that are distinguishable by 
their phenotype, amoeboid and mesenchymal. The difference in appearance and motility between 
the two single-cell modes are due to changes in membrane signaling, actin structure, myosin 
activity, expression of adhesion molecules, and gene expression (Figure 2) (Brábek et al., 2010). 
How the cells respond to the extracellular matrix (ECM) can favor the signaling programs for one 
of the two individual modes (Figure 2). Tumor cells can take advantage of these signaling 
programs and engage in different motility strategies when they encounter challenges like: ECM 
changes (Bergeman et al., 2016), anti-tumor therapies (Friedl and Alexander, 2011; Taddei et al., 
2014), immunosurveillance (Lorenzo-Sanz and Muñoz, 2019; Terry et al., 2017), and metabolic 
stress (Lehmann et al., 2017). 
Mesenchymal Cell Migration 
One of the two single-cell modes is the mesenchymal phenotype. Mesenchymal cell 
migration is classified by its use of adhesion molecules and matrix metalloproteinases (MMP) 
(Table 1) (Wolf et al., 2003). MMP are proteolytic enzymes that cleave and degrade large 
building blocks of the extracellular matrix, such as collagen and fibronectin. As a result, the 
proteolytic enzymes can remodel the ECM into a roadway and expose adhesion ligands, allowing 
cells to move towards their respective chemotactic or durotactic signals (Frantz et al., 2010). 
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Integrins are adhesion molecules on cells that bind to ECM components, like collagen or 
fibronectin, to create and activate focal adhesion clusters. These focal adhesions (FA) activate 
downstream signaling proteins to recruit and polymerize actin filaments at the leading-edge (front 
end of the cell) to create long spindle membrane extensions called lamellipodia (Nobes and Hall, 
1995) (Table 1; Figure 3).  
Along with lamellipodia, mesenchymal cells can also create filopodia at the leading-edge 
of the cell. Filopodia are smaller protrusions that not only help stabilize focal contacts by weakly 
binding to ECM, but are also able to respond to chemokines for directed migration (Caswell and 
Zech, 2018). Lamellipodia and filopodia are primarily regulated by polarized the RhoGTPases, 
Rac1 and Cdc42, at the leading-edge of the cell as a result of new focal adhesion activation 
(Nobes and Hall, 1995). Consequently, focal adhesion can establish cellular polarity through 
 
Figure 3: Modes of cell migration. Collective migration has leader cells with ability to degrade ECM for mobility. 
The trailing cells, which are behind the leader cells, have epithelial characteristics such as high levels of cell-cell 
junction E-cadherin. Epithelial-to-Mesenchymal Transition (EMT) is a process which allows collective-epithelial 
cells to transition into mesenchymal cells by decreasing E- cadherin junctions and increasing snail and twist 
transcription factors. The combination of signals allows the cell to rearrange actin and myosin to change cell shape 
and affect its mobility. Mesenchymal-to-Amoeboid Transition (MAT) is the transition from mesenchymal cell to 
amoeboid cells. Up-regulating RhoA and ROCK kinase further re-arranges actin and myosin along the membrane, 
around the cell to alter cellular mobility. Figure from: Brábek, J., Mierke, C.T., Rösel, D. et al. Cell Commun 
Signal (2010) 8: 22. Creative Commons: https://creativecommons.org/licenses/by/2.0/ 
 Mesenchymal migration Amoeboid migration 
Shape  Elongated, spindle shape, polarized  Round, irregular shape, non-polarized  
Protrusions  Lamellipodia  Blebs  
Adhesion  High adhesion Low adhesion 
Velocity  Slower Faster 
Protease  High activity Low activity 
Mobility  Traction-Force motility Propulsion-squeeze motility 
Table 1: differentiating traits between mesenchymal- and amoeboid-cell migration.  
11 
 
Rac1 and Cdc42 in mesenchymal cells. Since amoeboid cells cannot form mature focal 
adhesions, these cells will not initiate the necessary Rac1 and Cdc42 to shape and polarize the 
cell (Table 1; Figure 3). 
            Mesenchymal cells generate focal adhesions using integrins, which are membrane-bound 
molecules that bind to the 
ECM when they are in an 
active state (Figure 4). 
Active-integrin recruits 
adapter proteins and actin-
binding proteins like talin, 
vinculin and paxillin 
(Vicente-Manzanares et al., 
2009). Active Focal 
Adhesion Kinase (FAK) 
and Src Kinase then 
localize and bind to the 
adapter proteins that are 
bound to active adhesion 
molecules (Westhoff et al., 
2004). With FAK and Src 
Kinase at the membrane, the probability to activate Rac1 and Cdc42 increases. Active Cdc42, Rac1 
and P21-Activated Kinase (PAK) can activate Arp2/3 via WASP/WAVE activation (Figure 4) 
(Vicente-Manzanares et al., 2009). Arp2/3 is an actin-polymerizing protein that helps create the 
lamellipodia extension at the leading-edge, towards the direction of migration (Figure 4) (Panková 
et al., 2010; Vicente-Manzanares et al., 2009). At the trailing-end (the back of the cell), there is 
 
Figure 4: Many integrins bind to ECM components (collagen or fibronectin) to 
form focal adhesion complexes. Active integrin domains recruit actin-binding 
and adaptor proteins which facilitate activation of kinases  such as FAK and 
Src. This leads to activation of downstream effector proteins like RhoGTPases 
and PAK to activate WAVE and Arp2/3 for actin polymerization at the focal 
adhesion. Figure from: Vicente-Manzanares, M., Choi, C.K., and Horwitz, 
A.R. (2009). Integrins in cell migration--the actin connection. Journal of Cell 
Science 122, 199-206. By permission of Journal of Cell Science.  
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formation of actin-myosin stress fibers that mediate forward retraction of the rear. Localization of 
the stress fibers towards the rear is regulated by polarized RhoA activity at the trailing-end (Figure 
5). Displacement of mesenchymal cells is mediated by a traction force that is created when a cell 
forms focal adhesions and has polarized signaling of Rac in the front of the cell and RhoA in the 
back of the cell to coordinate mobility (Figure 5) (Pandya et al., 2017b). As a result, mesenchymal 
cell migration is typically slower compared to amoeboid cell migration because it must make new 
focal adhesions every time the cell moves forward (Pandya et al., 2017b). 
Cell movement is initiated when active focal adhesions cause the cell to anchor to the 
ECM and provide a point for traction-force (Figure 5). Active Rac1 and CDC42 at the leading-
edge  initiate 
formation of 
lamellipodia to 
extend the 
membrane past the 
current integrin 
anchor, and create 
multiple new focal 
adhesions in the 
direction of 
migration (Pandya et 
al., 2017b). At the trailing-end of the cell, myosin stress fibers contract and generate tension force 
between trailing- and leading-edges. Focal adhesions at the rear are weaker compared to the new 
and multiple focal adhesions at the front of the cell. Tension force from stress fiber contraction 
overcomes the anchor force at the rear, causing release of rear adhesion sites (Pandya et al., 
2017b). Once the rear is unbound, the stress fibers then facilitate membrane retraction and 
 
 
 
Figure 5: General mesencymal cell migration. Cells begins movement in response to a 
stimulus. Focal adhesion signaling initiates lamellipodia extensions in the direction of 
the stimulus and create focal adhesions. At the trailing-end of the cells there is 
increased contraction by stress fibers. Weakened rear adhesion points release and 
allow retraction of membrane for displacement.  Ridley, A.J. (2001). Rho GTPases 
and cell migration. Journal of Cell Science 114, 2713. By permission of Journal of 
Cell Science.  
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translocation of the membrane forward (Figure 5).  The old anterior adhesion points now serve as 
the posterior traction anchor, as the cell restarts lamellipodia extensions to continue the cycle 
(Figure 5) (Lauffenburger and Horwitz, 1996) (Sheetz et al., 1998). 
 Other distinctive features associated with mesenchymal cells include: increase in 
expression of N-cadherin (which is another adhesion molecule that binds to the extracellular 
matrix), increase in expression of vimentin (a well-known intermediate filament found in 
mesenchymal cells), decrease in E-cadherin expression (a cell-cell adhesion molecule), and 
increase in secretion of proteolytic proteins (Clark and Vignjevic, 2015; Panková et al., 2010).   
Amoeboid Cell Migration 
The second distinguishable mode of single-cell migration is amoeboid phenotype. It is 
phenotypically distinct from mesenchymal migration (Figure 3; Table 1). Amoeboid mode has a 
rounded cell shape and multiple smaller membrane protrusions called blebs (Figure 6). The 
migration is independent from any adhesion or proteolysis, which is the opposite of mesenchymal 
migration (Wolf et al., 2003). The differences in membrane protrusions and independence from 
ECM adhesions are a result of having a different actin-myosin organization (Byrne et al., 2016)  
The amoeboid cell phenotype is strongly correlated with higher levels of RhoA, which 
increase contraction of stress fibers throughout the cell. The contractions increase the intracellular 
pressure in the cell, which disrupt the actin along the cortical membrane (Figure 6) (Fackler and 
Grosse, 2008). Force generated from the pressure pushes the plasma membrane that has been 
detached from the actin cytoskeleton, creating blebbing (irregular-shaped) protrusion (Figure 6). 
The bleb shape is dependent on the degree of pressure created by actin-myosin activity (Pandya et 
al., 2017a, b). After the membrane is extended, there is recruitment of Ezrin-Radixin-Moesin 
(ERM) family proteins to the intracellular side of the membrane bilayer. ERM proteins help 
recruit RhoA and ROCK to the membrane to localize myosin (Fackler and Grosse, 2008). 
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Concentrated actin and myosin initiate contraction and retract the bleb back to its starting point 
(Figure 6) (Fackler and Grosse, 2008).  
 
When the cells are not able to form focal adhesion, displacement of amoeboid cell 
migration is achieved through retrograde flow of the plasma membrane, actin filaments, and 
myosin (O'Neill et al., 2018). Retrograde flow is maintained through endocytic lipid vesicles and 
driven by an actin-myosin contraction gradient (Figure 7) (Moreau et al., 2018; O'Neill et al., 
2018). Contractile stress from concentrated myosin at the rear and cortical membrane will cause 
actin filaments to break into individual protein monomers. Individual actin proteins then flow to 
the front of the cell to be added to the growing end of the actin structures, resulting in a retrograde 
flow of actin. Myosin will follow actin to continue making contractile units with actin, and 
together will move to the membrane (O'Neill et al., 2018). As the actin polymerizes, it generates 
very small membrane ruffle-protrusions that can generate frictional force between bilayer and 
 
 
Figure 6: A: Actomyosin dynamics in bleb formations. Increased hydroststaic presssure from rearward actomyosin 
contraction causes F-actin at the cortex to rupture. Plasma membrane is extended from pressure causing blebbing 
extensions. ERM proteins on the exposed plasma membrane recruit RhoA for myosin and actin reogranization 
along the membrane. New actomyosin along the bleb cortex retracts the plasma membrane back to the cell. Cylce 
continues to make consistent contacts along the matrix to facilitate displacement B: GFP-RhoA epxression is high 
along cortical membrane. F-actin red is highly expressed on cortical membrane. Colocalization of green RhoA and 
red F-actin is located at cortical membrae. Figure from Fackler, O.T., and Grosse, R. (2008). Cell motility through 
plasma membrane blebbing. The Journal of Cell Biology 181, 879. By permission Journal of Cell Biology.  
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extracellular matrix structures (Figure 7) (O'Neill et al., 2018). The non-specific frictional force 
causes a squeezing motion, resulting in cell displacement (Fackler and Grosse, 2008; Moreau et 
al., 2018).  
Interestingly, it is not just the membrane that moves during retrograde flow of actin, but 
also transmembrane proteins are flowing rearward (O'Neill et al., 2018). Fluorescent beads 
attached to the membrane bilayer were seen to be flowing and pushing rearward, towards an 
optically-stimulated RhoA, confirming the membrane flow and control by RhoA-myosin 
contractility (O'Neill et al., 2018). Labeled transmembrane proteins, like integrins or GPCR, and 
intracellular signaling lipids, like PIP2 or farnesyl lipid, are also flowing along with the 
membrane (Hawkins et al., 2011; O'Neill et al., 2018). As a result, there is an accumulation of 
important cortical actin proteins such as ezrin, moesin, and intracellular signaling lipids like PIP2, 
which can maintain or enhance RhoA signaling (O'Neill et al., 2018).  
 
Mobility can also be generated within viscous fluids exhibiting a swimming motility that 
is similar to the squeezing motility (O'Neill et al., 2018). The frictional forces from the membrane 
retrograde flow allow the cell to move in a low adhesion environment, a highly confined 
 
 
Figure 7: When cells are placed on ECM in the absence of adhesion, cells can create frictional forces between cell 
membrane and ECM molecules. Force is genertaed by continuous retrograde flow of actin. Retrograde flow is 
maintained by a polarized gradient of myosin and RhoA activity to apply stress on rear-actin filaments. 
Polyermization of actin causes force to be applied on membranes, the momentum force from protrusion  is 
transferred to ECM molecules causing the membrane to propel against the surface resulting in cell migration.  
Frinctional force is enhanced when cells are in confinement plus low adhesion enviroments. The rate of retrograde 
flow increases to account for the increased fictional forces in confinement. Figure From Moreau, H.D., Piel, M., 
Voituriez, R., and Lennon-Duménil, A.-M. (2018). Integrating Physical and Molecular Insights on Immune Cell 
Migration. Trends in Immunology 39, 632-643. By permission of Elsevier.  
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environment, and even in a viscous-fluid environment (Moreau et al., 2018; O'Neill et al., 2018). 
When amoeboid cells are placed in a confined or spatially restrictive environment (like small 
openings in the matrix), the frictional force is increased due to increased contact points along the 
cell membrane, which enhance motility even under very non-adhesive conditions. This 
mechanism is called “chimneying” (Moreau et al., 2018). Chimneying may explain why 
amoeboid cells are faster and favored under highly-confined matrix environments (Ruprecht et 
al., 2015). 
Once the cells are mobile, the directional cues can be interpreted differently between 
amoeboid and mesenchymal cells. Key mediators in directionality are durotaxis (movement along 
a stiffness gradient), chemotaxis (movement along a chemical gradient), and haptotaxis 
(movement along an adhesive-substrate gradient) (Bear and Haugh, 2014).  
Nuclear deformation is a large determinant in durotaxis. It can dictate the direction in 
which amoeboid cells move in a 3-dimentional (3D) matrix. 3D matrices contain many 
holes/pores with various sizes. A matrix with higher amounts of smaller size holes/pores has a 
rigid/stiff matrix made from higher concentration of ECM components, like collagen or 
fibronectin (Walker et al., 2018). In contrast, a softer matrix with larger holes/pores has a less 
rigid matrix made from less concentrated collagen or fibronectin (Walker et al., 2018). Amoeboid 
cells prefer to move onto areas of the matrix with larger-size holes (less rigid) to avoid nuclear 
stress/deformation, because it is not able to degrade the stiff matrix using proteases (Renkawitz et 
al., 2019). Amoeboid cells can select and direct their migration by using their nucleus as a gauge 
to assess pore size within the ECM and preferentially move towards loose-open matrix spaces. 
(Friedl et al., 2011; Renkawitz et al., 2019). The nucleus is a very large organelle, and it limits 
where the cell can move if it does not have a means to make the space larger. In contrast, when 
passing through smaller holes, mesenchymal cells can reposition their nucleus towards the back 
of the cell and secrete proteolytic enzymes at the leading-edge of the cell to make the pore size 
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larger (Friedl et al., 2011). Proteolysis of the ECM will also expose ECM ligands for the cell to 
create focal adhesions. Mesenchymal cells will prefer and be directed towards more rigid/stiff 
ECM, since it is able to increase ECM ligands to make focal adhesion and begin traction motility 
(Wolf et al., 2003). The two migration modes respond differently when exposed to the same 
durotactic signal because of their distinct perinuclear dynamics, ability to form adhesion, and 
ability to secrete proteases.  
 Haptotactic cues strongly influence mesenchymal cells, because of their dependence on 
adhesion molecules to drive motility. Mesenchymal cells move in the direction of high 
concentration of adhesion molecules, which differ from amoeboid cells that move independent of 
focal adhesion (Wolf et al., 2003). Durotaxis can be associated with haptotaxis, because adhesion 
molecules tend to be concentrated in very rigid/stiff matrix (Frantz et al., 2010; Wolf et al., 2003).  
Amoeboid cells under a chemokine gradient can respond similarly to mesenchymal cells, 
especially if the cell type is the same. However, when looking at distinct cell types, such as 
typical mesenchymal fibroblasts and amoeboid lymphocytes, their chemotactic sensing is 
mediated by different types of chemoattractant receptors (Bear and Haugh, 2014). Generally, 
amoeboid lymphocytes use G-Protein Coupled Receptor (GPCR) to sense interleukin or 
chemokine ligands for directional migration. Mesenchymal fibroblasts can express Receptor 
Tyrosine Kinase (RTK) receptors to sense their respective growth factors and drive migration 
towards the chemical signal (Bear and Haugh, 2014). Even though the downstream signaling of 
these receptors are intertwined, the regulation and inhibition of each is substantially different 
(Bear and Haugh, 2014), thus adding to the list of differential features between the two modes. 
Collective Cell Migration     
Aside from the two single-cell modes of migration, cells can move collectively while 
adhered with others in a cluster or in a stream of cells (Figure 3). A large determinant of this 
process is the ability to express junctional proteins, such as E-cadherin (cell-cell adhesion 
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molecule), which cause cells to remain stuck to each other as they move in the environment 
(Clark and Vignjevic, 2015). The collective group of cells has a leader cell that exhibits the 
properties of single-cell mesenchymal migration. The follower cells display an epithelial 
phenotype with high levels of E-cadherin (cell-cell junction), and has a basal-apical cell polarity 
(Pandya et al., 2017a). The leader cell is also interconnected with the follower cells through cell-
cell junction and an actin-myosin network (Fernandez-Gonzalez et al., 2009). As the leader cell 
moves forward, leader cells secrete proteases that degrade the ECM and create micro-tracks, 
which allow the epithelial cells to drag along (Figure 3) (Haeger et al., 2014; Pandya et al., 
2017a).  
Although the regulation of collective migration is more complex than a single-cell 
mesenchymal, they still share features, such as having a traction-mediated migration via focal 
adhesions (Pandya et al., 2017a). Leader cells project lamellipodial protrusions to create focal 
adhesions, and the lagging-epithelial end undergoes RhoA-ROCK-mediated contraction (Pandya 
et al., 2017a). Contraction is further enhanced by having the lagging-epithelial cells 
interconnected with other cells via cell-cell junctions, which allow synchronous contraction and 
retraction (Fernandez-Gonzalez et al., 2009). Coordinating lagging-end contraction with leading 
cells’ focal adhesions enables large-scale traction and retraction that is similarly seen in single-
cell mesenchymal migration (Figure 5) (Fernandez-Gonzalez et al., 2009; Friedl and Alexander, 
2011).  
Each cell mode has a differential response to a durotactic, heptotactic, and chemotactic 
signaling. This suggests that cells can transition between various modes of migration. Tumor cells 
can activate various signaling programs to create specific cell behavior and morphology when 
they are placed in a complex and changing extracellular matrix. 
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Changing the Extracellular Matrix 
 
Having a complex tumor environment that is composed of abnormal chemical and 
structural components can result in severe remodeling of the ECM. This leads to a new exposure 
of environmental cues for tumor cells and benign cells, which will affect the plasticity of cell 
migration (Brábek et al., 2010). The ECM acts as a physical scaffold and provides biochemicals 
cues to influence the gene expression of surrounding cells. The ECM composition is specific to 
tissue type and varies in biochemical and biophysical signaling. For example, in more soft-
compliant tissues, such as breast, prostate, and lung tissue, the matrix predominately has type I 
and III collagen with sparse fibronectin throughout, resulting in a high resistance against 
stretching forces (Alford et al., 2015). In stiffer matrices like bone tissue, the ECM is produced by 
osteoblasts secreting large amounts of type I collagen and inorganic minerals like hydroxyapatite, 
providing most of the bone mass. This reduces the matrix elastic capabilities but improves 
compressive resistance (Alford et al., 2015). In order to maintain  homeostasis in soft or hard 
ECM, there are specialized cells called fibroblasts within the ECM that secrete metalloproteases 
(MMP), crosslinking proteins (such as LOX), and the respective inhibitors for the proteases and 
crosslinking proteins when they are needed (Darby et al., 2014; Frantz et al., 2010).  
In pathological states such as chronic inflammation, wound healing, and tumorigenesis, 
the ECM homeostasis is compromised as a result of over-activated fibroblasts or osteoblasts. 
These remodeling cells cause drastic changes to the ECM leading to a softer or stiffer ECM, 
ultimately affecting ECM adhesive and spatial confinement properties (Brábek et al., 2010; Darby 
et al., 2014). The exposure of new mechanical signaling (such as confinement and adhesion) in 
the new pathogenic ECM will influence the migratory and behavior traits of stromal cells and 
tumor cells.  
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In tumors, a major player in remodeling the matrix is the population of cancer-associated 
fibroblasts (CAFs), also classified as myofibroblasts. CAFs are fibroblasts that have been 
overactivated by either tumor-secreted growth factors, physical stress from a stiffer matrix, and 
cell-cell signaling with a tumor cell (Wang et al., 2017). Normal fibroblasts are active in 
inflammatory process, wound healing, and tissue matrix remodeling (Grotendorst et al., 2004). 
Once fibroblasts complete their function during wound healing, they become inactive and 
undergo apoptosis (Darby et al., 2014). However, fibroblasts in a tumor environment are exposed 
to persistent signaling cues, which allow the cells to become constitutively active. Overactive 
fibroblasts are also seen in chronic inflammatory and in fibrotic diseases (Darby et al., 2014). 
With an increased population of CAFs in tumor environments, there is an overwhelming 
deposition of collagen and crosslinked proteins resulting in completely new and foreign 
environment (Wang et al., 2017). Topography of the matrix can also be affected by CAFs. These 
fibroblasts are able to  physically contract collagen fibers together to change the arrangement of 
the ECM (Pakshir et al., 2019).  
 In vivo and in vitro studies, and mathematical modelling, have shown that the 
composition of the ECM network has a profound effect on the mode of migration in neoplastic 
and benign cells. The combination of cell polarization, adhesion, contractility, and protease 
function, will dictate the appropriate mode of migration (Panková et al., 2010; Talkenberger et 
al., 2017; te Boekhorst et al., 2016). The possible mechanical signaling mechanisms that control 
these combinations are still not fully understood. A possible explanation could be found in the 
differential regulation of RhoGTPases in ECMs of different composition and biophysical 
signaling.    
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EMT and MAT: A Response to Changes in ECM  
Cells can sense their environment through chemical signals such as chemotactic 
gradients, growth factors, and lipid mediators. Binding of these chemical signals to appropriate 
surface or intracellular receptors cause systematic activation of proteins that are directly 
associated with the cytoskeleton and/or gene expression. As a result, such signals can change 
cellular adhesion and contractility in relation to a stimulus (Totaro et al., 2018). ECM structural 
components can transduce a mechanical signal by binding to surface receptors and/or directly 
apply membrane tension to also modulate gene expression or activity of cytoskeletal elements. 
The physical structures in the ECM and chemical signals will play a role in regulating the 
transition between modes of cell migration (Dupont et al., 2011). 
Epithelial-mesenchymal transition (EMT) is a dynamic transitory process between 
epithelial and mesenchymal cell phenotypes. EMT is an oscillating process with many 
intermediate stages between the two modes. Many studies have observed this EMT oscillation to 
be a part of tumor dissemination, especially with breast cancers cells (Bidard et al., 2008; 
Hüsemann et al., 2008; Nieto et al., 2016). EMT is initiated by several signaling factors that 
activate a set of transcription factors (TF) that control cell matrix-adhesion molecules, 
cytoskeleton networks, cell-cell adhesion and cell polarization (Figure 3). Major transcription 
factors that promote EMT include Snail, Zeb, and Twist (Brábek et al., 2010). Snail and Twist 
decrease the epithelial cell-cell junctions  (E-cadherin) to favor single-cell mesenchymal 
migration (Brábek et al., 2010). Other transcriptional regulation for EMT includes miRNA and 
post-translational modification (Peixoto et al., 2019).   
EMT is associated with aggressive metastatic breast cancer because the process allows 
benign-immobile tumor cells to transition into mobile-mesenchymal cells. By increasing 
expression of mesenchymal factors like N-cadherin (for cell-matrix adhesion) during EMT, it 
allow cells to adopt a traction-force motility (Figure 8) (Nieto et al., 2016). There is also similar 
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co-expression of epithelial- and mesenchymal-markers in disseminating-circulatory tumor cells 
(tumor cells in the vasculature) suggesting that these cells are undergoing EMT while 
metastasizing (Gupta and Maitra, 2016; Pastushenko and Blanpain, 2019) (Nieto et al., 2016).  
Focusing on mechanotransduction, breast cancer cell lines can increase EMT phenotypes 
through two distinct pathways, Twist1-G3BP2 and Yap/Taz pathways. These pathways use two 
different transcription factors that promote EMT when cells are placed in a stiff matrix 
environment (Totaro et al., 2018). If epithelial cells are placed in a dense and stiff environment, it 
causes the cells to stretch and elongate resulting in an increase in actin tension in the cell. The 
actin tension causes the Yap/Taz transcription factor to activate and localize to the nucleus to 
activate mesenchymal genes (Dupont et al., 2011; Pastushenko and Blanpain, 2019). Similarly, 
dense and stiff matrices have a higher concentration of substrate adhesion that result in higher 
amounts of focal adhesion signaling. Higher focal adhesion signaling causes an increase of 
integrin-dependent phosphorylation of G3BP2, a membrane anchor protein (Wei et al., 2015). 
Phosphorylation of G3BP2 causes a change in its structure and releases the Twist transcription 
factor from its regulatory domain. Release from G3BP2 membrane anchor, allows Twist to 
localize to the nucleus to activate mesenchymal genes like N-cadherin and suppression of 
epithelial E-cadherin for EMT (Wei et al., 2015).  
In tumor cells, mesenchymal-to-amoeboid transition (MAT) is thought to be a subsequent 
step from EMT, but epithelial-to-amoeboid transition can also be seen (Figure 8) (Friedl and 
Wolf, 2010). The regulation of MAT is mediated by growth factors, cytokines, cell-ECM 
interactions and chemokines (Friedl and Wolf, 2010). Generally, if a signal can change a cell’s 
proteolytic activity or cell-ECM adhesion abilities, it can result in MAT or AMT (amoeboid-to-
mesenchymal transition) (Figure 8) (Matsuoka and Yashiro, 2014). A tumor cell experiences 
these change in signals when they are exposed to foreign ECM conditions. Tumor cells that are 
transferred to a stiffer/dense matrix are exposed to high amounts of adhesion ligands which cause 
23 
 
integrin signaling to increase and favors expression of proteolytic enzymes via Rac1 activation 
(Wolf et al., 2003). Tumor cells in a softer and loose matrix have lower adhesion, resulting in 
higher levels of RhoA and cortical actomyosin organization to promote a round amoeboid 
phenotype. Therefore, MAT can be initiated by increasing RhoA and decreasing Rac1 to favor 
amoeboid phenotype (Figure 8). Increasing spatial confinement has also been shown to increase 
cortical contractility to enhance amoeboid behavior in low adhesion conditions (Figure 9) (Liu et 
al., 2015). The response of increased contractility, in low adhesion and high confinement,  is too 
rapid to be linked to a transcriptional program, and cells are not adhered to a substrate, which 
rules-out any active adhesion signaling programs (Liu et al., 2015). The mechanical mechanism 
that promote this increase in cortical contractility is still unknown. Direct changes to the cell 
membrane or loss of adhesion signaling, in high confinement and low adhesion, may cause a 
change in RhoGTPases to increase cortical contractility and support amoeboid cell migration for 
MAT.  
 
 
Figure 8: Transition from collective or epithelial cell migration into mesenchymal migration is caused by changes 
to transcriptional program mediated by Snail and Twist, which leads to a decrease in cell-cell junctions. 
Mesenchymal to amoeboid transition is facilitated by decreased expression of proteases, integrin adhesion and 
increase actomyosin contractility via Rho/ROCK induction and decreased Rac. The Rho/ROCK signaling also 
reorganizes the f-actin cytoskeleton around the membrane. Differential activity and expression of these proteins 
results in unique cell shape and behavior. Mesenchymal cells display an elongated shape with integrin at leading-
edge and actomyosin at trailing-end. Amoeboid cells display a round shape with increased cortical actomyosin 
structures and do not have integrin adhesions. Figure from: Rho/ROCK signaling in motility and metastasis of 
gastric cancer. World Journal of Gastroenterology 20, 13756-13766. Permission by Creative Commons; 
https://creativecommons.org/licenses/by-nc/4.0/ 
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Aside from tumor cells, macrophages are also able to transition between mesenchymal 
and amoeboid migration in response to changes in the ECM (McWhorter et al., 2013).  
Macrophages can differentially exhibit M1 (pro-inflammatory, round, flat, less polarized) vs M2 
(pro-healing, elongated, spindle, polarized) phenotypes, when exposed to different ECM 
environments (McWhorter et al., 2013). Macrophages in a dense collage matrix, with very small 
pores, take on a mesenchymal/M2 phenotype and increases protease secretion to break down 
collagen (McWhorter et al., 2013). At low-density collagen, with large size holes, macrophages 
adopt the amoeboid/M1 phenotype. Like tumor cells, there is a rearrangement of cytoskeleton 
proteins and a change in gene expression to exhibit the different phenotypes, solely through a 
change in the cell-ECM interaction (Pakshir et al., 2019; Čermák et al., 2018). Macrophage 
behavior and cell shape changes are dependent on actomyosin organization and level of 
contractility, both of which are controlled by the RhoA-ROCK signaling pathway (Parri and 
Chiarugi, 2010). During inhibition of myosin, RhoA, and ROCK, there is a loss of polarization of 
 
Figure 9: A: Increase in contractility of a cell, induce by confinment, and decreasing adhesion, promotes 
mesenchymal transition into amoeboid mode of migration. B,C Increased adhesion past a certain threshold 
promotes mesenchymal mode regardless of contractility. Decreasing adhesion favors amoeboid mode but the 
shape of amoeboid cells is dependent on the level contractility which can be changed by spatial confinement. Liu, 
Y.-J., Le Berre, M., Lautenschlaeger, F., Maiuri, P., Callan-Jones, A., Heuzé, M., Takaki, T., Voituriez, R., and 
Piel, M. (2015). Confinement and Low Adhesion Induce Fast Amoeboid Migration of Slow Mesenchymal Cells. 
Cell 160, 659-672. Permission by Elsevier. 
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the M2 and M1 phenotypes, when cultured in varying matrix stiffness as described above 
(McWhorter et al., 2013). The RhoA-ROCK pathway must be involved in the transitory process 
between mesenchymal and amoeboid phenotypes in tumor cells and macrophages.   
Amoeboid migration is predominately seen in highly metastatic melanoma and breast 
cancer cell lines (Taddei et al., 2014). Circulating breast cancer cells in blood vessels also exhibit 
an amoeboid migration (Holle et al., 2019). Due to its flexible membrane and independence from 
cell-ECM adhesion, MAT is favorable for metastasis. Amoeboid cells can squeeze through tight 
spaces such as endothelial junctions (Reid et al., 2017) to aid in intravasation, mobility in fluids 
and extravasation from blood vessels (Holle et al., 2019). Once in circulation, amoeboid 
migration is also significantly faster compared to mesenchymal cell migration, which can play a 
factor survivability (O'Neill et al., 2018). It is reasonable to conclude that in some cell types, the 
MAT plays a large role in initiating metastasis, making it necessary to further understand how 
this process is enhanced or reduced under different ECM conditions such as stiffness, adhesion 
and confinement. Changes to RhoA activity are seen to drive mesenchymal cells to transition into 
ameoboid. Next, we will explore how regulation of RhoA is affected when tumor cells are placed 
in a low adhesion environment.  
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Bistable Signaling between RhoA and Rac1: Controlling 
Mesenchymal-Amoeboid Transition in Low Adhesion.  
RhoA and Rac1 can control the transition between modes of migration, but first we will 
review the function and regulation of RhoGTPases. GTPases are molecular switches that control 
the activity of 
biochemical pathways. 
They are found in two 
conformations, an off-
state and an on-state. The 
protein conformation is 
regulated by the binding 
of GTP (Bar-Sagi and 
Hall, 2000). When GTP 
binds to a GTPase it 
causes a switch to an 
active conformation, allowing interactions with different effector proteins to create a cellular 
response (Rush, 1995). When GDP is bound to the GTPase, it is in an inactive conformation and 
prevents the interaction with effectors proteins. Although GTPases have the intrinsic ability to 
catalyzes GTP into GDP, it is very slow and needs the help of an additional enzyme to regulate 
the GTPase activity (Rush, 1995). GTPase-activating proteins (GAPs) bind to the GTPase and 
enhance the catalysis of GTP to GDP to deactivate the GTPase protein when its activity is not 
needed (Figure 10). Guanine nucleotide exchange factors (GEFs) can switch GDP with GTP to 
activate the GTPase in response to a stimulus and cause a response (Figure 10) (Rush, 1995).  
 
Figure 10: RhoGTPases family members (Cdc42, Rac1, RhoA) are swtiches that 
use GTP to change confomrational states. On-state is when GTP is bound to 
protein. GEF facillitates the exhange of GDP for GTP to activate the GTPase. 
GAP will enhance hydrolysis of GTP to GDP to  inactivate the GTPase. Each 
GTPase has a specilized signaling function which is initiated by interacting with 
other proteins when GTPase is active. Cdc42 controls filopodia, Rac1 controls 
lamellipodia, and RhoA controls actomyosin stress fibers. Tsukada Y, Aoki K, 
Nakamura T, Sakumura Y, Matsuda M, Ishii S (2008). PLoS Comput Biol 4(11); 
Permission by Creative Commons; 
https://creativecommons.org/licenses/by/4.0/ 
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Each member of the RhoGTPases family will have a different effect on cell actin 
organization: Cdc42 will create actin filopodia when it is active, Rac1 will produce lamellipodia, 
and RhoA controls actomyosin stress fibers (Tsukada et al., 2008).  RhoGTPases have a diverse 
range of chemical and mechanical signaling that can modulate their activity. Rac1 and RhoA are 
the main regulators of cellular contractility and membrane protrusion (Byrne et al., 2016; Huang 
et al., 2014; Nobes and Hall, 1995; Parri and Chiarugi, 2010). As a result, MAT is strongly 
affected by the balance between RhoA or Rac1 GTPases (Figure 11).  
RhoA and Rac1 have a bistable relationship through a double-negative feedback. A 
double-negative feedback is when two molecules have a negative interaction with each other, and 
if one is overactive it will decrease the negative effect from the second molecule (Figure 11).  
RhoA and Rac1 activity can be controlled by either cell-ECM adhesion (Carragher et al., 2006), 
chemical signaling by growth factors (Huang et al., 2014), cell-polarizing signals (Gandalovičová 
et al., 2016), and Rho-GAPs and -GEFs (Sanz-Moreno et al., 2008), all of which are dysregulated 
within a tumor microenvironment (Clark and Vignjevic, 2015).  
 
Figure 11: Double-negative feedback of Rho and Rac1 via PAK signaling. Biochecmical inputs like focal adhesion 
will activate PAK and increase Rac1 singaling and decrease RhoA by PAK inhibition on RhoA, promoting 
mesenchymal migration. If PAK is inhibited, RhoA is increased, from lack of inhibition, and RhoA will inhibit 
Rac1via RacGAP and pomote amoeboid migration. Figure from: Byrne, Kate M., Monsefi, N., Dawson, John C., 
Degasperi, A., Bukowski-Wills, J.-C., Volinsky, N., Dobrzyński, M., Birtwistle, Marc R., Tsyganov, Mikhail A., 
Kiyatkin, A., et al. (2016). Bistability in the Rac1, PAK, and RhoA Signaling Network Drives Actin Cytoskeleton 
Dynamics and Cell Motility Switches. Cell Systems 2, 38-48. Permission by creative commons; 
https://creativecommons.org/licenses/by/4.0/ 
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Changes in ECM adhesion can cause a shift in the RhoA/Rac1 bistable double-negative 
network towards one extreme, facilitating the transition between modes of migration (Figure 11). 
For example, tumor cells with overactivation of RhoA increase contractility levels and rearrange 
the actin cytoskeleton to be concentrated along cortical membranes, creating an amoeboid round-
shaped cell (Ruprecht et al., 2015). In contrast, cells with higher Rac1activity, favor actin 
polymerization at leading-edges, creating lamellipodia and increased adhesion complexes for 
mesenchymal migration (Huang et al., 2014). Biochemically, Rac1 and RhoA are antagonistic to 
each other and are even found to be polarized at opposite ends of the cell (Nobes and Hall, 1995; 
Tsukada et al., 2008). Rac1 is anterior and concentrated toward the direction of movement, while 
RhoA is found posterior to the leading-edge. Distinct polarization of RhoA and Rac1 is more 
apparent during mesenchymal migration, while amoeboid cells have overwhelming RhoA 
throughout the cells and low levels of activated Rac1(Tsukada et al., 2008). This suggests that 
RhoA upstream signaling and its downstream functions have a very important role in regulating 
the transition to the amoeboid phenotype, further supporting our model (Figure 1). 
The double negative relationship between RhoA and Rac1, as described above, is linked 
to the p21-activated kinase (PAK), which is highly dependent on focal adhesions (Byrne et al., 
2016). As the cell experiences changes to the ECM, it affects the stimulus for PAK activation and 
ultimately decides which RhoGTPase is favored by being able to control the double-negative 
network (Figure 11) (Byrne et al., 2016). Cells that form focal adhesion activate Rac1 to 
phosphorylate and activate PAK. Active PAK is now able to inhibit RhoA and remove the 
inhibition on Rac1 (Figure 11). Inhibiting RhoA further enhances Rac1 and PAK activation to 
maintain and overactivated Rac1 signaling, as seen in mesenchymal migration (Parri and 
Chiarugi, 2010). If a tumor cell is in a low adhesion space, where it is not able to form focal 
adhesions (like in soft matrix), then perhaps PAK will not be activated and will not inhibit RhoA 
signaling (Itakura et al., 2013).  RhoA is released from its inhibition, allowing it to interact with 
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Rac1 to reduce the activity (Figure 11) (Parri and Chiarugi, 2010). Overall there are higher levels 
of RhoA in low cell-ECM adhesion environments which promote an increase of cortical myosin 
for amoeboid migration  (Figure 1) (Byrne et al., 2016).  FAK (Arriagada et al., 2019), Src kinase 
(Westhoff et al., 2004) and Yap/Taz (Nardone et al., 2017) are similar signaling components, like 
PAK, that are dependent on focal adhesion and influences Rac1/ RhoA double-negative 
mechanism. The MAT seen during low stiffness/low adhesion matrix could be explained by 
diminished PAK activity as a result of the lack of focal adhesion signaling. In soft matrix, there is 
less ligand exposed for integrins to bind and activate downstream components like PAK, FAK, 
Src and Yap/Taz, which could result in decreased Rac1 and increased RhoA for cortical 
actomyosin favoring amoeboid phenotype, which is consistent with our low adhesion model 
(Figure 1) (Bergert et al., 2012; Byrne et al., 2016; Friedl and Alexander, 2011; Liu et al., 2015).  
Experimental manipulation (optogenetic control) of Rac1 GAPs and GEFs has  shown 
them to be integral in establishing a spatial gradient of Rac1 and RhoA in cells to maintain 
mesenchymal and amoeboid migration (de Beco et al., 2018). DOCK3 is a GEF that is able to 
affect the RhoA/Rac1 signaling module (Sanz-Moreno et al., 2008).  DOCK3 is localized at 
protruding ends of a mesenchymal cell to activate and maintain Rac1 (Sanz-Moreno, 2012). The 
DOCK3-Rac1 pathway can increase WAVE2 to decrease myosin activity and suppress an 
amoeboid phenotype (Figure 12) (Sanz-Moreno, 2012; Sanz-Moreno et al., 2008). Tumor cells in 
a stiff matrix form many focal adhesion complexes that recruit NEDD9, an adaptor protein, to 
form a complex with DOCK3. The complex is then able to transduce integrin signaling into Rac1 
activation (Figure 12). The NEDD9 and DOCK3 complex can also enhance integrin signaling to 
activate more Src and FAK which further inhibits RhoA and maintains a mesenchymal phenotype 
(Figure 12) (Jones et al., 2017; Sanz-Moreno et al., 2008). Loss of focal adhesion (in softer 
matrix) results in a loss of the DOCK3 and NEDD9 complex, which leads to decreased Rac1-
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mediated inhibition of RhoA. 
Active RhoA is now able to 
increase cortical contractility  
(Figure 12) (Sanz-Moreno et al., 
2008). Downregulation of Rac1 is 
also mediated by activating 
ArhGAP22 (a Rac1-GAP),  
preventing the negative regulation 
on to RhoA/ROCK and 
contractility in the cell (Sanz-
Moreno et al., 2008). Regulation of 
Rho-GAPs and GEFs during 
changes in cell-ECM adhesion, 
demonstrate the importance of 
Rho/ Rac1 in controlling mesenchymal-amoeboid transition.  
Recycling and degradation of Rac1 and RhoA can regulate signaling polarization and 
therefore control migratory phenotype (Gandalovičová et al., 2016). Clathrin- and Rab5-mediated 
endocytosis is able to control the activation of Rac1 in a cell (Palamidessi et al., 2008). Clathrin is 
a protein that coats and forms membrane vesicles. Rab5 is a protein that sorts endosome vesicles 
and helps fuse vesicles to the membrane (Arriagada et al., 2019).  Spatial trafficking of Rac1 to 
the leading-edge membrane controls the cell polarity that is crucial for mesenchymal migration. 
Rab5-mediated endocytosis is initiated by growth factors signaling, like Hepatocyte Growth 
Factor (HGF), at the leading-edge of a cell. HGF initiates clathrin recruitment to form a 
membrane vesicle. Rab5 finalizes early endosome formation and can recruit Rac1 along with 
Tiam1 (a Rac1-GEF). The localization of Rac1 and Tiam1 at the early endosome increases their 
 
Figure 12: Similarly to PAK, NEDD9 can regulate the RhoA and 
Rac1 balance. NEDD9 is an adapter protein that is active with 
mature focal adhesions. Once active it can bind and activate DOCK3 
(GEF for Rac). Rac GEF will activate Rac1 and drive tractional 
motility via lamellipodia. NEDD9 can also recruit Src and FAK to 
the integrin so they can be activated. Src and FAK will act on ROCK 
to inhibit actomyosin contractility to favor mesenchymal migration. 
If cells are placed in softer matrix, they will not be able to induce 
NEDD9 activation due to a lack of focal adhesions, resulting in  
RhoA-ROCK activation and contacility which promotes the 
amoeboid mode. Sanz-Moreno, V. (2012). Tumour Invasion: A New 
Twist on Rac-Driven Mesenchymal Migration. Current Biology 22, 
R449-R451. Modified. Permission by Elsevier.  
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interaction and favors the active Rac1 conformation (Palamidessi et al., 2008). Colocalization of 
Rac1 and Tiam1 is increased when cells are placed in a stiff matrix (Palamidessi et al., 2008). 
Rac1 is activated and recycled at leading-edges through endosomes creating a signaling gradient, 
which is a hallmark of mesenchymal migration. Impairing Rab5 endocytosis will drastically 
impede Rac1 activity and display a round-amoeboid phenotype (Palamidessi et al., 2008). 
Although the exact scaffolding mechanism of active Rac1 and Tiam1 to leading-edge endosomes 
is not known, Rab5 is still a determinate in polarization rac1, and consequently RhoA, through its 
double-negative network. Rab5 is also reported to be dependent on active-integrin complexes at 
the leading-edge (Arriagada et al., 2019). Loss of adhesion complexes under soft matrix 
conditions may promote MAT by prevent Rac1 trafficking and polarization to the leading-edge. 
Local degradation of Rho GTPases can also help establish cell polarity, shape, and 
behavior. Smurf1 is an enzyme that can degrade RhoA and decrease cortical contractility (Sahai 
et al., 2007). Smurf1 is recruited by a Cdc42-dependent polarity complex comprising of PAR6-
aPKC (Sahai et al., 2007). Cdc42 is predominately localized at the leading-edge of mesenchymal 
cells, like Rac1. If there is a loss of cell polarity, the PAR6-aPKC complex will fail to form and 
will not activate Smurf1 (Sahai et al., 2007). RhoA will not be degraded and can now favor the 
amoeboid mode. The most common way cells can lose their polarity is if there is a loss of 
adhesion (cell-cell or cell-ECM), and that is most frequently seen when cells are in a soft matrix, 
due to the lack of stable ligands (Gandalovičová et al., 2016). 
We saw the importance of integrin in Rac1 activation, so it is reasonable to speculate that 
integrin turnover affects the signaling of Rac1 and therefore Rho in a cell (Carragher et al., 2006). 
At active focal adhesions, FAK is recruited to activate Src kinase. Src kinase is able to act on 
calpain-2, a proteolytic protein that cleaves focal adhesion components (such as FAK, talin, 
actinin, integrin, and paxillin) resulting in disassembly of the adhesion complex (Westhoff et al., 
2004). Integrin disassembly is necessary to create new traction point during mesenchymal 
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migration. Inhibition of calpain-2 will prevent new integrin adhesion and the cell will remain 
immobile. Lack of integrin complexes impairs Rac1 activation and its negative feedback on 
RhoA, allowing a higher cortical contractility and imposes an amoeboid phenotype (Carragher et 
al., 2006). Calpain-2 can modulate the activity of Rac1, and in low adhesion condition can help 
promote MAT.  
Aside from adhesion signaling or chemical signaling, another possible regulatory 
component of the RhoA/Rac1 network is through mechanosensing membrane proteins. 
Syndecan-4 is a membrane proteoglycan that functions to transiently sense ECM components like  
collagen (Elfenbein and Simons, 2013). Syndecan-4 is not an adhesion molecule. It is a 
transmembrane protein that can transduce environmental cues to the cytoskeleton by 
intracellularly binding to Src, cortactin, and tubulin (Elfenbein and Simons, 2013). As the cell 
receives the signaling, it causes remodeling of the actin cytoskeleton to optimize the migration, 
like MAT. This is achieved through syndecan’s modulation of RhoA regulation (Elfenbein and 
Simons, 2013; Helen K. Matthews  2008). Rac1 can inhibit syndecan signaling, but in the 
absence of focal adhesion signaling, Rac1 activity is reduced. Under low adhesion, syndecan can 
move to the membrane to further reduce activity of Rac1 and promotes RhoA activity, in favor of 
the amoeboid phenotype (Helen K. Matthews  2008). 
MAT can be seen when tumor mesenchymal cells are placed in a soft ECM with no 
adhesion. This adaptation is thought to be mediated by perturbed membrane signaling (Killaars et 
al., 2019) or by altering adhesion signaling (Liu et al., 2015; Čermák et al., 2018). These changes 
in adhesion and membrane signaling causes diverse effects on various signaling programs which 
ultimately modulate the RhoA and Rac1 double-negative network. These pathways are consistent 
with our model in low adhesion. Next, we will see how high confinement, along with low 
adhesion, can also enhance cortical contractility to influence MAT.  
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Bistable Signaling in Amoeboid Cells in High Confinement and 
Low Adhesion Environments 
Low adhesion conditions favor mesenchymal to amoeboid transition in transformed cells. 
The cells are switching modes of migration solely based on differences in environmental 
parameters. Recent research has shown that if the cells experience mechanical pressure, from 
being in a confined space, mesenchymal cells can transition into the amoeboid phenotype, as well 
(Liu et al., 2015). Confinement in a tumor environment can be developed from high cell density 
regions due to uncontrolled replication, and from an in increase collagen deposition and 
crosslinking proteins by cancer associated fibroblast (CAF) or other tumor cells (Friedl and Wolf, 
2010). A possible mechanism for MAT in confinement may involve some mechanical regulation 
of the double-negative RhoA/Rac1 module in order to favor RhoA-ROCK-myosin activity 
without gene expression changes or adhesion signaling.  
When a cell is in a confined space the membrane experiences an increase in tension as it 
is being stretched and squeezed 
(Hung et al., 2016). Consequently, 
it affects mechanically-sensitive 
membrane proteins. One example 
is the membrane bound calcium 
cation stretch channel, PIEZO1, 
which is sensitive to membrane 
stretching and can increase cortical 
myosin organization when 
activated (Figure 13) (Hung et al., 
2016). In response to increased 
 
Figure 13: Confinements causes quick activation of calcium stretch 
channels, PIEZO1. PEIZO1–Ca2+ release deactivates PKA. PKA directly 
phosphorylates RhoA and or RhoGEF for inhibition. Inhibting PKA will 
increase RhoA and increase contractility for amoeboid migration. Hung, 
W.-C., Yang, J.R., Yankaskas, C.L., Wong, B.S., Wu, P.-H., Pardo-
Pastor, C., Serra, S.A., Chiang, M.-J., Gu, Z., Wirtz, D., et al. (2016). 
Confinement Sensing and Signal Optimization via Piezo1/PKA and 
Myosin II Pathways. Cell Reports 15, 1430-1441. Permission by Creative 
Commons; https://creativecommons.org/licenses/by/4.0/ 
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membrane tension, the PIEZO1 channels open and increase intracellular Ca2+ which activates of 
PDE1, a phosphodiesterase to deactivate PKA (Figure 13) (Hung et al., 2016). PKA directly 
phosphorylates either RhoA or Rho-GEF, causing inhibition of these proteins (Hung et al., 2016). 
The double-negative relationship between Rac1 and RhoA allows Rac1 to be active when RhoA 
is inhibited by PKA. During confinement, the increased intracellular calcium prevents PKA from 
inhibiting RhoA, and pushes the equilibrium towards RhoA-ROCK module for increased myosin 
contractility (Figure 13). Moreover, myosin can regulate other mechanosensing mechanisms 
which leads to enhancement of the initial contractility (Jacobelli et al., 2010). Myosin can also 
inhibit PKA and negatively regulate Rac1 (Hung et al., 2016). Additionally,  Ca2+ influx can also 
directly enhance myosin contractility through calmodulin singling, which may contribute to 
maintenance of a cell transition state under confinement (Hung et al., 2016). Overall, PEIZO 
stretch channels link the increased RhoA-dependent-myosin activity with increasing cell 
confinement.   
Another way tumor cells can mechanically regulate MAT may be through syndecan-4 
regulation. Syndecan-4 can inhibit RhoE signaling through PKCa which results in prolonged 
activity of RhoA (Elfenbein and Simons, 2013). RhoE is a membrane-bound GTPase that directly 
 
Figure 14: i) Rear section of cell in low adhesion and confinement cell. Syndecan-4 is transported to the rear of the 
cell creating protein clusters that faiciliate increased activation of PKCa. PKCa then inhibits RhoE which reduces 
inhibtion on RhoA at cortical memrbane. Overall, there is increased RhoA-dependent myosin localization on 
cortical memrbanes as a result of a high confinement and low adhesion environemnt.  
ii) Memebrane flow of a cell in a confined, low adhesion evnironment. Membrane and transmembrane proteins 
like integrin, flow rearward. Inactive integrins are internalized to be recycled, preventing Rac1 activation and 
favoring RhoA actviation as a result of their double-negative relationships.  
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inactivates ROCK kinase via binding, which will limit ROCK interaction with myosin. Inhibition 
of RhoE leads to increase actin-myosin contractility that is seen in bleb protrusion retraction 
(Riento et al., 2003). A possible regulator upstream of RhoE is PKCa. PKCa is a membrane-
bound protein that is controlled by syndecan-4 signaling (Nakashima, 2002). PKCa also controls 
the uptake of integrin which is used for focal adhesion signaling (Elfenbein and Simons, 2013). 
As integrin is endocytosed, syndecan signaling overshadows integrin activity, favoring RhoA 
activation (Elfenbein and Simons, 2013). Tumor amoeboid cells in high confinement spaces will 
exhibit increased retrograde flow of the membrane and transmembrane proteins to facilitate cell 
displacement. Syndecan-4 could be transported to the rear of the cell leading to aggregated 
clusters of sydencan-4; these clusters can then overtly recruit PKCa (Figure 14i). Increased 
localization of PKCa to the membrane is activated by diacylglycerol (DG) or Ca2+ release 
(Nakashima, 2002). PKCa recruits and concentrates membrane-bound RhoE for inhibition 
(Nakashima, 2002). Therefore, there will be an overactivation of RhoA as a result of the high 
confinement environment (Figure 14i).  
The increased membrane flow, in confinement and low adhesion, may also translocate 
inactive integrin proteins to the rear, allowing integrin internalization as the cell tries to recycle 
the lipids from the membrane, back to the front of the cell to continue the retrograde cycle (Figure 
14ii) (O'Neill et al., 2018). Endocytosis of inactive integrins could enhance in loss of Rac1 and 
increase of RhoA (Figure 14ii) (Byrne et al., 2016). Overall, low adhesion and high confinement 
causes MAT in tumor cells through RhoA and Rac1 signaling module, in support of the low 
adhesion model (Figure 1 and Figure 14). If we can to control the regulation of these 
RhoGTPases then it could be used in antitumor therapies to prevent MAT and deter tumor 
invasion.  
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Conclusion 
In vivo, tumor cells are exposed to a complex tumor environment. The environments the 
tumor cells experiences are not so well defined like in experimental parameter: having only stiff 
or soft matrix, and having high or low confinement, but rather it is a mixture of all these 
variables. We saw that each mode of migration is generated when the tumor cells are introduced 
into their respective conditions, but will it remain in its newly transformed phenotype or will it 
continuously change if tumor cells are in this always-changing environment? A group recently 
proposed a gradient model, where at the extremes of these confinement and adhesion conditions, 
there is the distinct amoeboid migration with dominant RhoA at one end, and mesenchymal 
migration with 
dominant Rac1 at the 
other end (Figure 15) 
(Holle et al., 2019). 
This consistent with our 
low-adhesion model 
controlling 
RhoGTPase. In-
between these extreme 
points, however, lies an intermediate mode exhibiting both amoeboid and mesenchymal 
characteristics with balanced Rac1 and RhoA activity. This idea conflicts with our model, 
positing that it is not a binary switch between extreme RhoA and Rac1 as explained before, but 
rather, a gradient. Perhaps this suggests that there is intrinsic regulation that finely tunes 
RhoGTPase activity, instead of pushing towards one extreme like what we have explored with 
low adhesion and confinement. We have yet to explore if intermediate levels of adhesion can 
exhibit mixed phenotype as seen by Holle et al. (Figure 15).  Understanding how these 
 
Figure 15: A gradient model, where at the extremes of these confinement and 
adhesion conditions, there is the distinct mesenchymal mode and at the other end 
is the amoeboid mode. In between, there is an intermediate mode exhibiting both 
amoeboid and mesenchymal characteristics. Holle, A.W., Govindan Kutty Devi, 
N., Clar, K., Fan, A., Saif, T., Kemkemer, R., and Spatz, J.P. (2019). Cancer Cells 
Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid 
Transition. Nano Letters 19, 2280-2290. Permission by Creative Commons; 
https://creativecommons.org/licenses/by/4.0/ 
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intermediate cells (under a mixed low/high confinement condition) preferentially choose their 
mode of migration may be the next step in understanding how cell confinement and adhesion 
contribute to cell plasticity through RhoGTPase regulation. 
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Appendix 
Figure 1: Self-created   
Figure 2: Creative Commons; https://creativecommons.org/licenses/by-nc-sa/3.0/ 
Figure 3: Creative Commons; https://creativecommons.org/licenses/by/2.0/ 
Figure 4: By permission of Journal of Cell Science: 
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Figure 5: by permission of Journal of Cell Science: 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: By permission Journal of Cell Biology. 
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Figure 7: by permission of Elsevier  
 
 
Figure 8: Permission by Creative Commons; https://creativecommons.org/licenses/by-nc/4.0/ 
Figure 9: Permission by Elsevier:   
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Figure 10: Permission by Creative Commons; https://creativecommons.org/licenses/by/4.0/ 
Figure 11: Permission by Creative Commons; https://creativecommons.org/licenses/by/4.0/ 
Figure 12: Permission by Elsevier. 
 
Figure 13: Permission by Creative Commons; https://creativecommons.org/licenses/by/4.0/ 
Figure 14: self-created  
Figure 15: Permission by Creative Commons; https://creativecommons.org/licenses/by/4.0/ 
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